Progress towards reduced-dose pneumococcal vaccine schedules for children in Africa
- PMID: 36934732
- DOI: 10.1016/S2352-4642(23)00055-X
Progress towards reduced-dose pneumococcal vaccine schedules for children in Africa
Conflict of interest statement
We declare no competing interests. This work was supported by a Wellcome Trust Programme Grant (grant number 091909/Z/10/Z) and the Malawi-Liverpool-Wellcome Programme Core Award (grant number 206454) from the Wellcome Trust. BK-A is supported by Wellcome (grant number 224354/Z/21/Z). PI is supported by the European and Developing Countries Clinical Trials Partnership (grant number RIA2017MC-2013 EMPIRICAL).
Comment on
-
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial.Lancet Child Adolesc Health. 2023 May;7(5):326-335. doi: 10.1016/S2352-4642(23)00025-1. Epub 2023 Mar 16. Lancet Child Adolesc Health. 2023. PMID: 36934731 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical